InMode (INMD) Projected to Post Quarterly Earnings on Tuesday

InMode (NASDAQ:INMD) is anticipated to announce its Q4 2025 results before the market opens on Tuesday, February 10th. Analysts expect the company to announce earnings of $0.4167 per share and revenue of $104.6420 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, February 10, 2026 at 8:30 AM ET.

InMode Trading Up 5.8%

Shares of NASDAQ:INMD opened at $16.62 on Tuesday. The company has a market cap of $1.05 billion, a price-to-earnings ratio of 7.69 and a beta of 2.19. The company has a 50-day moving average price of $14.56 and a 200-day moving average price of $14.66. InMode has a 12 month low of $13.14 and a 12 month high of $19.78.

Institutional Investors Weigh In On InMode

Several hedge funds and other institutional investors have recently added to or reduced their stakes in INMD. Advisory Services Network LLC purchased a new position in InMode during the third quarter valued at $37,000. Polymer Capital Management HK LTD bought a new position in shares of InMode in the 3rd quarter worth about $199,000. Boothbay Fund Management LLC bought a new position in shares of InMode in the 3rd quarter worth about $166,000. Lazard Asset Management LLC purchased a new position in InMode during the 3rd quarter valued at about $1,851,000. Finally, Cooper Creek Partners Management LLC bought a new stake in InMode during the third quarter worth about $14,980,000. 68.04% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on INMD. Weiss Ratings restated a “sell (d+)” rating on shares of InMode in a report on Thursday, January 22nd. Needham & Company LLC reissued a “hold” rating on shares of InMode in a research note on Friday, October 10th. Canaccord Genuity Group set a $15.00 target price on InMode and gave the company a “hold” rating in a report on Wednesday, December 17th. UBS Group cut their price target on shares of InMode from $16.25 to $16.00 and set a “neutral” rating on the stock in a report on Thursday, November 6th. Finally, BTIG Research reissued a “neutral” rating on shares of InMode in a research report on Monday, January 26th. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $16.60.

About InMode

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.